BRICS Infusion Services Market Size and Forecast by Offering, Therapy Type, Administration Route, and Reimbursement Model: 2019-2033

  Feb 2026   | Format: PDF DataSheet |   Pages: 160+ | Type: Niche Industry Report |    Authors: Prayag Singh (Asst. Manager)  

 

BRICS Infusion Services Market Outlook

  • In 2025, the market in BRICS stood at USD 74.49 billion, showing a year-over-year growth rate of 12.0%.
  • By 2033, the BRICS Infusion Services Market will attain USD 243.73 billion, with a projected CAGR of 16.0% across the forecast window.
  • Emerging economy healthcare investment is strengthening specialty hospital infrastructure, driving expansion of infusion-based oncology and autoimmune treatment programs.
  • BRICS health ministers’ joint declarations highlight coordinated focus on cancer control and biologic access, reinforcing systemic therapy growth momentum.
  • DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation. [Learn more]

Market Scope Framework

Offering

  • Facility-Based Infusion Services
  • Home Infusion Therapy Services
  • Office-Based Physician Infusion Services
  • Specialty Biologic Administration Programs
  • Chronic Therapy Infusion Management Programs

Therapy Type

  • Oncology Infusions
  • Autoimmune and Inflammatory Therapy
  • Anti-Infective Therapy
  • Nutritional and Metabolic Infusion
  • Neurology and Rare Disease Infusion

Administration Route

  • Intravenous (IV)
  • Subcutaneous
  • Epidural / Intrathecal
  • Intra-Arterial

Reimbursement Model

  • Fee-for-Service
  • Bundled Episode-Based
  • Capitated / Risk-Based
  • Hybrid Contracting

Countries Covered

  • Brazil
  • Russia
  • India
  • China
  • South Africa
×

Request Sample

CAPTCHA Refresh